Nuclear Medicine Therapeutics Market Report

Global and Region Nuclear Medicine Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：141
  • REPORT CODE：GMM922542
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Nuclear Medicine Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nuclear Medicine Therapeuticsmarket, defines the market attractiveness level of Nuclear Medicine Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nuclear Medicine Therapeutics industry, describes the types of Nuclear Medicine Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nuclear Medicine Therapeutics market and the development prospects and opportunities of Nuclear Medicine Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nuclear Medicine Therapeutics market in Chapter 13.

    By Player:

    • NTP Radioisotopes

    • IBA Group

    • Triad Isotopes

    • Siemens Healthcare (PETNET Solutions)

    • Lantheus Medical Imaging

    By Type:

    • Alpha Emitters

    • Beta Emitters

    • Brachytherapy

    By End-User:

    • Application 1

    • Application 2

    • Application 3

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nuclear Medicine Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nuclear Medicine Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nuclear Medicine Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nuclear Medicine Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nuclear Medicine Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Nuclear Medicine Therapeutics Consumption (2017-2022)

    • 7.2 United States Nuclear Medicine Therapeutics Consumption (2017-2022)

    • 7.3 Europe Nuclear Medicine Therapeutics Consumption (2017-2022)

    • 7.4 China Nuclear Medicine Therapeutics Consumption (2017-2022)

    • 7.5 Japan Nuclear Medicine Therapeutics Consumption (2017-2022)

    • 7.6 India Nuclear Medicine Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Nuclear Medicine Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Nuclear Medicine Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Nuclear Medicine Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Nuclear Medicine Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Nuclear Medicine Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Nuclear Medicine Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Nuclear Medicine Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Nuclear Medicine Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Nuclear Medicine Therapeutics Consumption Forecast (2022-2028)

    9 Global Nuclear Medicine Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Nuclear Medicine Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Alpha Emitters Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Beta Emitters Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Brachytherapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nuclear Medicine Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Application 1 Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Application 2 Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Application 3 Consumption and Growth Rate (2017-2022)

    10 Global Nuclear Medicine Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Nuclear Medicine Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Alpha Emitters Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Beta Emitters Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Brachytherapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nuclear Medicine Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Application 1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Application 2 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Application 3 Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nuclear Medicine Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nuclear Medicine Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nuclear Medicine Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nuclear Medicine Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nuclear Medicine Therapeutics Market Competitive Analysis

    • 14.1 NTP Radioisotopes

      • 14.1.1 NTP Radioisotopes Company Details

      • 14.1.2 NTP Radioisotopes Nuclear Medicine Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 NTP Radioisotopes Nuclear Medicine Therapeutics Product and Service

    • 14.2 IBA Group

      • 14.2.1 IBA Group Company Details

      • 14.2.2 IBA Group Nuclear Medicine Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 IBA Group Nuclear Medicine Therapeutics Product and Service

    • 14.3 Triad Isotopes

      • 14.3.1 Triad Isotopes Company Details

      • 14.3.2 Triad Isotopes Nuclear Medicine Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Triad Isotopes Nuclear Medicine Therapeutics Product and Service

    • 14.4 Siemens Healthcare (PETNET Solutions)

      • 14.4.1 Siemens Healthcare (PETNET Solutions) Company Details

      • 14.4.2 Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Product and Service

    • 14.5 Lantheus Medical Imaging

      • 14.5.1 Lantheus Medical Imaging Company Details

      • 14.5.2 Lantheus Medical Imaging Nuclear Medicine Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Lantheus Medical Imaging Nuclear Medicine Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nuclear Medicine Therapeutics

    • Figure Nuclear Medicine Therapeutics Picture

    • Table Global Nuclear Medicine Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nuclear Medicine Therapeutics Consumption by Country (2017-2022)

    • Figure United States Nuclear Medicine Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Nuclear Medicine Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Nuclear Medicine Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Nuclear Medicine Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Nuclear Medicine Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nuclear Medicine Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Nuclear Medicine Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Nuclear Medicine Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nuclear Medicine Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nuclear Medicine Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nuclear Medicine Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nuclear Medicine Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nuclear Medicine Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alpha Emitters Consumption and Growth Rate (2017-2022)

    • Figure Global Beta Emitters Consumption and Growth Rate (2017-2022)

    • Figure Global Brachytherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Application 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Application 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Application 3 Consumption and Growth Rate (2017-2022)

    • Figure Global Alpha Emitters Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Beta Emitters Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Brachytherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 3 Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nuclear Medicine Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nuclear Medicine Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table NTP Radioisotopes (Foundation Year, Company Profile and etc.)

    • Table NTP Radioisotopes Nuclear Medicine Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table NTP Radioisotopes Nuclear Medicine Therapeutics Product and Service

    • Table IBA Group (Foundation Year, Company Profile and etc.)

    • Table IBA Group Nuclear Medicine Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table IBA Group Nuclear Medicine Therapeutics Product and Service

    • Table Triad Isotopes (Foundation Year, Company Profile and etc.)

    • Table Triad Isotopes Nuclear Medicine Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Triad Isotopes Nuclear Medicine Therapeutics Product and Service

    • Table Siemens Healthcare (PETNET Solutions) (Foundation Year, Company Profile and etc.)

    • Table Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Product and Service

    • Table Lantheus Medical Imaging (Foundation Year, Company Profile and etc.)

    • Table Lantheus Medical Imaging Nuclear Medicine Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Medical Imaging Nuclear Medicine Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US